NeoGenomics (NEO)
NASDAQ:NEO
US Market
Advertisement

NeoGenomics (NEO) Technical Analysis

Compare
1,907 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
NeoGenomics’s (NEO) Moving Averages Convergence Divergence (MACD) indicator is 0.30, suggesting NeoGenomics is a Buy.
NeoGenomics’s (NEO) 20-Day exponential moving average is 10.00, while NeoGenomics’s (NEO) share price is $10, making it a Sell.
NeoGenomics’s (NEO) 50-Day exponential moving average is 9.25, while NeoGenomics’s (NEO) share price is $10, making it a Buy.

NeoGenomics (NEO) Pivot Points

Nov 13, 2025, 09:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.09
10.18
10.30
10.40
10.52
10.61
10.73
Fibonacci
10.18
10.26
10.31
10.40
10.48
10.53
10.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NeoGenomics (NEO) Moving Averages

Nov 13, 2025, 09:51 AM
Period
Simple
Exponential
MA5
10.26Sell
10.20Sell
MA10
10.11Sell
10.18Sell
MA20
10.21Sell
10.00Sell
MA50
9.15Buy
9.25Buy
MA100
7.89Buy
8.84Buy
MA200
8.71Buy
10.02Sell
NeoGenomics’s (NEO) 10-Day exponential moving average is 10.18, while NeoGenomics’s (NEO) share price is $10, making it a Sell.
NeoGenomics’s (NEO) 100-Day exponential moving average is 8.84, while NeoGenomics’s (NEO) share price is $10, making it a Buy.
NeoGenomics’s (NEO) stock price is $10 and NeoGenomics’s (NEO) 50-day simple moving average is 9.15, creating a Buy signal.
NeoGenomics’s (NEO) stock price is $10 and NeoGenomics’s (NEO) 100-day simple moving average is 7.89, creating a Buy signal.
NeoGenomics’s (NEO) stock price is $10 and NeoGenomics’s (NEO) 200-day simple moving average is 8.71, creating a Buy signal.

NeoGenomics (NEO) Technical Indicators

Nov 13, 2025, 09:51 AM
Name
Value
Implied Action
RSI (14)
52.71
Neutral
STOCH (9,6)
64.21
Neutral
STOCHRSI (14)
42.86
Neutral
MACD (12,26)
0.30
Buy
ADX (14)
29.39
Neutral
Williams %R
-70.87
Buy
CCI (14)
-10.02
Neutral
ATR (14)
0.54
-
Ultimate Oscillator
46.11
Neutral
ROC
-4.31
Sell
NeoGenomics’s (NEO) Relative Strength Index (RSI) is 52.71, creating a Neutral signal.
NeoGenomics’s (NEO) Trend Strength Indicator (ADX) is 29.39, creating a Neutral signal.
NeoGenomics’s (NEO) Commodity Channel Index (CCI) is -10.02, creating a Neutral signal.
NeoGenomics’s (NEO) Price Rate of Change (ROC) is -4.31, creating a Sell signal.

FAQ

Is NEO a Buy, Hold, or Sell?
Based on NEO’s technical indicators, NEO is a Hold.
    What is NEO’s RSI (14)?
    NEO’s RSI (14) is 52.71, which suggests NEO is a Neutral.
      What is NEO’s MACD?
      NEO’s MACD is 0.30, which suggests NEO is a Buy.
        What is NEO’s 5-day moving average?
        NEO’s 5-day moving average is 10.26, which suggests NEO is a Sell.
          What is NEO’s 20-day moving average?
          NEO 20-day moving average is 10.21, which suggests NEO is a Sell.
            What is NEO’s 50-day moving average?
            NEO’s 50-day moving average is 9.15, which suggests NEO is a Buy.
              What is NEO’s 200-day moving average?
              NEO’s 200-day moving average is 8.71, which suggests NEO is a Buy.
                What is NEO’s Williams % R (14)?
                NEO’s Williams % R (14) is -70.87, which suggests NEO is a Buy.
                  What is NEO’s CCI (14)?
                  NEO’s CCI (14) is -10.02, which suggests NEO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis